Germany's Merz Pharma Offers to Buy Obagi for $383.5M
German drugmaker Merz Pharma said Tuesday that it wants to buy dermatology products maker Obagi for about $383.5 million, topping a previous offer from Valeant.
skin care
Male Vanity Gets Thrifty: Mansome Men Watch Their Wallets, Too
Nearly a decade after the metrosexual appeared, it has become de rigeur for men to primp, exfoliate and emulsify. But today's "mansome" man is interested in more than just getting the right look -- he wants the right price as well.
